After completion of her Masters, Sudha started her career in clinical research at Clinigene International Ltd, sister concerns of Biocon. She has worked in clinical research industry for the past five and a half years and was part of George Clinical for nearly four years.

Sudha has had experience in working on academic trials and seeks to pursue higher education and training in public health research, especially in the areas of non-communicable diseases including mental health and injuries.

She is currently involved in a study where mobile-based technology is being used to provide basic mental health care to scheduled tribe villages in rural Andhra Pradesh. 

Maree is responsible for designing, leading, and delivering a distinctive and vibrant postgraduate, postdoctoral and future leader research experience at The George. Maree and her team provide management and oversight of ‘higher degree by research’ candidates, their supervisors, visiting fellows and work with the training team to co-ordinate postgraduate research training.

Maree also leads a program of research focusing on developing simple, cost-effective strategies to prevent depression and significantly improve the outcome for people with chronic disease.

Maree works one day per week as a Professor of Epidemiology in the Faculty of Health and Wellbeing at The University of Central Lancashire in the United Kingdom.

Anna is working as an Associate Project Manager working on the STARS (stroke) and STEPCARE (cardiac arrest) studies. Since joining The George Institute in 2019 she has worked as a Senior Clinical Research Associate on various studies, both in Critical Care as well as other medical fields.  Prior to her employment at The George Institute, Anna was a Clinical Trials and Research Coordinator for the Intensive Care Units at Western Health, Victoria.  Anna has also worked as a Clinical Research Associate for Orion Clinical Services (CRO) and as a Research Coordinator for the Gastroenterology Department at Box Hill Hospital.  She also has a Bachelor of Biomedical Science with Honors from the University of South Australia, a Postgraduate Diploma in Forensic Science from La Trobe University and a Postgraduate Certificate in Business Administration from Swinburne University.

Dr Kotwal is a clinical nephrologist at the Prince of Wales Hospital in Sydney; Program Head of the Renal and Metabolic Division at The George Institute for Global Health and a Conjoint Senior Lecturer at UNSW. Her research interests include novel and pragmatic clinical trials and she is passionate about increasing clinical trial access for patients with kidney disease and personalised medicine. Dr Kotwal is the Academic Project Director for the GKPTN and the principal investigator for the Glomerular Disease Registry and Biobank in Sydney. She has expertise in translating research into clinical practice and in-depth knowledge of statistical techniques, epidemiology and clinical trial design.

Ben is a doctor from the UK and Advanced Trainee in nephrology who is completing a PhD at the George Institute. The focuses of the PhD is improving the outcomes and economics of treating chronic kidney disease with a particular interest in low-and-middle-income countries. Ben is also involved with the Affordable Dialysis Project – an initiative run by The George Institute to develop a system that can provide low cost dialysis to those who currently cannot afford it. He works as clinical advisor for this project.

Dr Land is a Senior Program Manager at The George Institute for Global Health, where she leads global initiatives to transition the world’s salt supply to potassium-enriched alternatives. This work addresses the urgent global challenge of high sodium intake and its associated health risks, advancing innovative strategies to improve cardiovascular health worldwide.

Prior to her current role, Dr Land held several key positions at the World Health Organization. Including playing a crucial role in the development and implementation of the highly successful global cervical cancer elimination program. Her leadership and strategic expertise were instrumental in advancing the initiative forward, securing essential support and securing commitments for its implementation.

With a robust background in both hands-on program implementation and high-level advisory roles, Dr Land continues to shape and advance global health policies and practices.